Literature DB >> 27226513

Role of Imaging in Diagnosing and Staging Pancreatic Cancer.

Mahmoud Al-Hawary1.   

Abstract

Imaging is a key component of diagnosis and staging of pancreatic cancer. CT, MRI, and endoscopic ultrasound are the most used and approved imaging modalities. The updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pancreatic Adenocarcinoma feature a recently published Pancreatic Ductal Adenocarcinoma Radiology Reporting Template endorsed by the Society of Abdominal Radiology and the American Pancreatic Association. The goal of the template is to standardize the reporting of the imaging findings and to improve communication among the various team members treating patients with pancreatic cancer, to ensure appropriate patient management.
Copyright © 2016 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2016        PMID: 27226513     DOI: 10.6004/jnccn.2016.0191

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  5 in total

1.  Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer.

Authors:  Nguyen H Tran; Vaibhav Sahai; Kent A Griffith; Hari Nathan; Ravi Kaza; Kyle C Cuneo; Jiaqi Shi; Edward Kim; Christopher J Sonnenday; Clifford S Cho; Theodore S Lawrence; Mark M Zalupski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-09-05       Impact factor: 7.038

2.  Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer.

Authors:  Dayang Chen; Xiongbo Wu; Min Xia; Fang Wu; Junli Ding; Yang Jiao; Qiang Zhan; Fangmei An
Journal:  Oncol Rep       Date:  2017-08-24       Impact factor: 3.906

3.  Optimal resection area for superior mesenteric artery nerve plexuses after neoadjuvant chemoradiotherapy for locally advanced pancreatic carcinoma.

Authors:  Takahiro Einama; Hirofumi Kamachi; Yosuke Tsuruga; Toshihiro Sakata; Kazuaki Shibuya; Yuzuru Sakamoto; Shingo Shimada; Kenji Wakayama; Tatsuya Orimo; Hideki Yokoo; Toshiya Kamiyama; Norio Katoh; Yusuke Uchinami; Tomoko Mitsuhashi; Akinobu Taketomi
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

4.  A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.

Authors:  Junliang Chen; Huaitao Wang; Lei Zhou; Zhihao Liu; Xiaodong Tan
Journal:  J Clin Lab Anal       Date:  2022-03-25       Impact factor: 3.124

5.  Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods.

Authors:  Xuejiao Han; Jing Yang; Jingwen Luo; Pengan Chen; Zilong Zhang; Aqu Alu; Yinan Xiao; Xuelei Ma
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.